Stock Analysis

View All
PANW daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY, Stage 2 (Advancing), as of August 31, 2026 at 01:14 — CANSLIM Research

PANW Stage 2 Uptrend Intact; Bull Flag Setup Near 396 Pivot

Palo Alto Networks (PANW) is trading in a Stage 2 advancing trend, holding above a…

Read More
NIO daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY, Stage 3→4 (Topping / Early Decline), as of August 31, 2026 at 01:13 — CANSLIM Research

NIO Breaks Below 30-Week MA as Stage 3→4 Topping Signals Distribution Risk

NIO is exhibiting a Stage 3 to Stage 4 transition, with the 30-week moving average…

Read More
MDT daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY, Stage 3 (Topping), as of August 31, 2026 at 01:12 — CANSLIM Research

MDT forms Cup with Handle near pivot; Stage 3 topping keeps sentiment neutral

Medtronic (MDT) is tracing a 38-week Cup with Handle base, with the handle currently resolving…

Read More

FRO Earnings Miss: Revenue Surge Masks EPS Shortfall

FRO delivered a compelling narrative of aggressive expansion, with year-on-year revenue surging by nearly 67%, driven largely by its core product lines and market penetration. However, the company narrowly missed analyst expectations on earnings per share, reporting 2.61 against a consensus of 2.62, representing a -0.49% surprise. This divergence suggests that while top-line growth remains robust, operating leverage is currently under pressure, likely due to increased investment in capacity or supply chain adjustments.

AFRM Earnings: Massive EPS Beat Signals Stage 2 Momentum

AIRM Holdings reported extraordinary financial results on 27 August 2026, delivering an EPS of $4.63 against a consensus estimate of merely $0.35, representing a staggering 1,233% surprise. This performance was underpinned by revenue growth of 32.6% year-on-year, driven by accelerated adoption of its proprietary AI infrastructure and expanding enterprise contracts. The market’s reaction to such a dramatic earnings beat suggests that the company has successfully navigated earlier operational hurdles, now entering a phase of significant scale-up.

S Earnings Miss: Revenue Growth Masks Profit Decline

Shares of S delivered disappointing results on 27 August 2026, with reported earnings per share falling to -0.27 against a consensus estimate of -0.23, representing a negative surprise of 16.51%. While revenue demonstrated impressive year-on-year growth of 20.8%, the miss in profitability suggests underlying operational headwinds are outweighing top-line momentum. The market’s reaction reflects concerns over cost structures and margin erosion rather than a fundamental breakdown of the business model.

RBRK Earnings: Massive Beat Signals Stage 2 Momentum

Robinson Biologics (RBRK) has demonstrated exceptional operational execution, reporting earnings that significantly outperformed market expectations. The company achieved an EPS of $0.20 against a consensus estimate of just $0.04, representing a remarkable 409% surprise. This performance was supported by revenue growth of nearly 39% year-on-year, indicating that the business model is scaling effectively despite the early-stage nature of its operations.

MRVL Earnings: AI Chip Demand Drives Strong Beat

Microchip reported fiscal results that comfortably exceeded analyst consensus, posting EPS of $0.94 against a forecast of $0.93, representing a positive surprise of 0.99%. This performance was underpinned by robust revenue growth of 27.6% year-on-year, reflecting sustained demand for high-performance computing and data centre solutions. The company’s ability to maintain margins while scaling output signals strong operational execution in the current AI hardware cycle.

GAP Earnings: Massive EPS Beat Yet Price Stalls in Stage 4

Gap Inc. has announced financial results that fundamentally alter the risk-reward profile for investors, posting an EPS of $1.38 against a consensus estimate of just $0.49—a staggering 180% surprise. While year-on-year revenue growth remains modest at roughly 1%, this performance is underpinned by aggressive cost-cutting measures and improved gross margins rather than top-line expansion. The market’s reaction to such a significant earnings beat typically warrants a bullish re-rating, yet the current price action suggests that institutional sentiment is still heavily weighed down by structural headwinds in the apparel sector.